Shilpa Medicare Secures SEC-CDSCO Nod for Nor-Ursodeoxycholic Acid Tablets, Eyes Market Launch for NASH
RAICHUR,India,March 12,2025--Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED),a leading API and formulation manufacturer,announces that the Subject Expert Committee (SEC) of CDSCO has approved